Lab News

CONCORD, Mass. — Bacainn Therapeutics, Inc., a Company developing novel therapies to address uncontrolled inflammation, today announced thesuccessful completion of the company’s Phase 1, first-in-human clinical trial of BT051, a novel, orally administered, gut-selective inhibitor of migration and activation of neutrophils.

New study led by John Haran will follow elderly participants from Worcester area for two years

Outpatients with mild-to-moderate COVID-19 will be enrolled in clinical study of microbiome metabolic therapy at UMass Chan Medical School

Study shows that patients with Alzheimer's have distinctly different microbiomes. 

Nearly 30 percent of nursing home residents carry the potentially fatal intestinal bacteria Clostridium difficile. To address this growing public health problem, physician-scientist John Haran, MD, PhD, and collaborators are focusing on the microbiome as a conduit to reduce the risk of C. diffinfection in nursing homes.

Researchers hope their findings will lead to development of treatments for gut disorders.

Researchers dramatically boosted sensitivity to chemotherapy and rendered tumors ‘almost undetectable’.

Meet Ana Maldonado-Contreras, a researcher in the Lab of Beth McCormick at the UMass Chan Medical School. Ana's research involves bacteria and contributes to our understanding of how bacteria communicate with each other and the cells of the intestine.

UMass Chan Medical School scientists Beth McCormick, PhD; Oliver Rando, MD, PhD; and Celia Schiffer, PhD, have been elected fellows of the American Academy of Microbiology for their scientific achievement and original contributions to the field of microbiology.

McCormick marries her love of science with music!
Beth McCormick, PhD, spends long hours in the lab, seeking to understand the bacterial pathogenesis of the gastrointestinal and respiratory tracts. Outside the lab, she likes to play drums. While research and music may seem like disparate interests, Dr. McCormick says they are actually complementary.

Research conducted in UMMS labs, with UMMS mentors, qualifies for national competition.